Hepatitis Monthly

Published by: Kowsar

Prevalence and Risk Factors of HCV/HIV Co-Infection and HCV Genotype Distribution in North-Eastern Poland

Anna Grzeszczuk 1 , * , Alicja Danuta Wandalowicz 1 , Jerzy Jaroszewicz 1 and Robert Flisiak 1
Authors Information
1 Department of Infectious Diseases and Hepatology, Medical University of Bialystok, Bialystok, Poland
Article information
  • Hepatitis Monthly: July 01, 2015, 15 (7); e27740
  • Published Online: July 22, 2015
  • Article Type: Research Article
  • Received: February 6, 2015
  • Revised: March 5, 2015
  • Accepted: April 25, 2015
  • DOI: 10.5812/hepatmon.27740v2

To Cite: Grzeszczuk A, Wandalowicz A D, Jaroszewicz J, Flisiak R. Prevalence and Risk Factors of HCV/HIV Co-Infection and HCV Genotype Distribution in North-Eastern Poland, Hepat Mon. 2015 ; 15(7):e27740. doi: 10.5812/hepatmon.27740v2.

Copyright © 2015, Kowsar Corp. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
5. Discussion
  • 1. Weber R, Ruppik M, Rickenbach M, Spoerri A, Furrer H, Battegay M, et al. Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV Med. 2013; 14(4): 195-207[DOI][PubMed]
  • 2. van der Helm J, Geskus R, Sabin C, Meyer L, Del Amo J, Chene G, et al. Effect of HCV infection on cause-specific mortality after HIV seroconversion, before and after 1997. Gastroenterology. 2013; 144(4): 751-760 e2[DOI][PubMed]
  • 3. Rockstroh JK, Peters L, Grint D, Soriano V, Reiss P, Monforte A, et al. Does hepatitis C viremia or genotype predict the risk of mortality in individuals co-infected with HIV? J Hepatol. 2013; 59(2): 213-20[DOI][PubMed]
  • 4. Weber R, Sabin CA, Friis-Moller N, Reiss P, El-Sadr WM, Kirk O, et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med. 2006; 166(15): 1632-41[DOI][PubMed]
  • 5. Niedzwiedzka-Stadnik M, Rosinska M. [HIV and AIDS in Poland in 2010]. Przegl Epidemiol. 2012; 66(2): 315-23[PubMed]
  • 6. Niedzwiedzka-Stadnik M, Rosinska M. HIV and AIDS in Poland in 2011. Przegl Epidemiol. 2013; 67(2): 267-72[PubMed]
  • 7. Rosinska M, Zielinski A. Recent increase in HIV rate by age, cohort, period analysis of surveillance data suggests changes in HIV epidemiology in Poland. Cent Eur J Public Health. 2011; 19(3): 123-7[PubMed]
  • 8. Rosinska M, Radziszewski F, Stepien M. [Hepatitis C in Poland in 2010]. Przegl Epidemiol. 2012; 66(2): 287-92[PubMed]
  • 9. Rosinska M, Parda N, Stepien M. Hepatitis C in Poland in 2011. Przegl Epidemiol. 2013; 67(2): 247-51[PubMed]
  • 10. Cornberg M, Razavi HA, Alberti A, Bernasconi E, Buti M, Cooper C, et al. A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel. Liver Int. 2011; 31 Suppl 2: 30-60[DOI][PubMed]
  • 11. HIV infections in Poland. Epidemiological reports.
  • 12. Aydin OA, Yemisen M, Karaosmanoglu HK, Sargin F, Gunduz A, Ceylan B, et al. Low Prevalence of Hepatitis C Virus Infection Among HIV-Positive Patients: Data From a Large-Scale Cohort Study in Istanbul, Turkey. Hepat Mon. 2014; 14(8)[DOI][PubMed]
  • 13. Rockstroh JK, Mocroft A, Soriano V, Tural C, Losso MH, Horban A, et al. Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy. J Infect Dis. 2005; 192(6): 992-1002[DOI][PubMed]
  • 14. Panasiuk A, Flisiak R, Mozer-Lisewska I, Adamek A, Tyczyno M, Halota W, et al. Distribution of HCV genotypes in Poland. Przegl Epidemiol. 2013; 67(1): 11-6[PubMed]
  • 15. Chlabicz S, Flisiak R, Lapinski TW, Kowalczuk O, Wiercinska-Drapalo A, Pytel-Krolczuk B, et al. Epidemiological features of patients infected with HCV genotype 4 in Poland: Epidemiology of HCV genotype 4 in Poland. Hepat Mon. 2011; 11(3): 191-4[PubMed]
  • 16. Tyczyno M, Halota W, Nowak W, Pawlowska M. Distribution of HCV genotypes in the populations of inmates in polish prison potulice and patients hospitalised in bydgoszcz. Hepat Mon. 2014; 14(5)[DOI][PubMed]
  • 17. Grabczewska, E. , Pawłowska, M. , Halota, W. . Epidemiological aspects of HCV/HIV co-infections. HIV AIDS Rev. 2003; 2/3(4): 123-6
  • 18. Niedzwiedzka-Stadnik M, Pielacha M, Rosinska M. HIV and AIDS in Poland in 2012. Przegl Epidemiol. 2014; 68(2): 283-9[PubMed]
  • 19. Peters L, Grint D, Lundgren JD, Rockstroh JK, Soriano V, Reiss P, et al. Hepatitis C virus viremia increases the incidence of chronic kidney disease in HIV-infected patients. AIDS. 2012; 26(15): 1917-26[DOI][PubMed]
  • 20. Urbanus AT, Van De Laar TJ, Geskus R, Vanhommerig JW, Van Rooijen MS, Schinkel J, et al. Trends in hepatitis C virus infections among MSM attending a sexually transmitted infection clinic; 1995-2010. AIDS. 2014; 28(5): 781-90[DOI][PubMed]
  • 21. Orsetti E, Staffolani S, Gesuita R, De Iaco G, Marchionni E, Brescini L, et al. Changing characteristics and risk factors of patients with and without incident HCV infection among HIV-infected individuals. Infection. 2013; 41(5): 987-90[DOI][PubMed]
  • 22. van de Laar T, Pybus O, Bruisten S, Brown D, Nelson M, Bhagani S, et al. Evidence of a large, international network of HCV transmission in HIV-positive men who have sex with men. Gastroenterology. 2009; 136(5): 1609-17[PubMed]
  • 23. Ishikane M, Watanabe K, Tsukada K, Nozaki Y, Yanase M, Igari T, et al. Acute hepatitis C in HIV-1 infected Japanese Cohort: single center retrospective cohort study. PLoS One. 2014; 9(6)[DOI][PubMed]
  • 24. Chlabicz S, Bonifatiuk I, Radziwon P. Prevalence of hepatitis C virus antibodies among blood donors in north-eastern Poland. Hepatol Res. 2005; 33(3): 206-10[DOI][PubMed]
  • 25. Soriano V, Mocroft A, Rockstroh J, Ledergerber B, Knysz B, Chaplinskas S, et al. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe. J Infect Dis. 2008; 198(9): 1337-44[DOI][PubMed]
  • 26. Arain A, Robaeys G, Stover H. Hepatitis C in European prisons: a call for an evidence-informed response. BMC Infect Dis. 2014; 14 Suppl 6[DOI][PubMed]
  • 27. Semaille C, Le Strat Y, Chiron E, Chemlal K, Valantin MA, Serre P, et al. Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy. Euro Surveill. 2013; 18(28)[PubMed]
  • 28. Saiz de la Hoya P, Marco A, Garcia-Guerrero J, Rivera A, Prevalhep study G. Hepatitis C and B prevalence in Spanish prisons. Eur J Clin Microbiol Infect Dis. 2011; 30(7): 857-62[DOI][PubMed]
  • 29. Marco A, Gallego C, Cayla JA. Incidence of hepatitis C infection among prisoners by routine laboratory values during a 20-year period. PLoS One. 2014; 9(2)[DOI][PubMed]
  • 30. Treso B, Barcsay E, Tarjan A, Horvath G, Dencs A, Hettmann A, et al. Prevalence and correlates of HCV, HVB, and HIV infection among prison inmates and staff, Hungary. J Urban Health. 2012; 89(1): 108-16[DOI][PubMed]
  • 31. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology. 2013; 57(4): 1333-42[DOI][PubMed]
  • 32. Martinez-Rebollar M, Mallolas J, Perez I, Gonzalez-Cordon A, Lonca M, Torres B, et al. [Acute outbreak of hepatitis C in human immunodeficiency virus-infected patients]. Enferm Infecc Microbiol Clin. 2015; 33(1): 3-8[DOI][PubMed]
  • 33. Flisiak R, Halota W, Horban A, Juszczyk J, Pawlowska M, Simon K. Prevalence and risk factors of HCV infection in Poland. Eur J Gastroenterol Hepatol. 2011; 23(12): 1213-7[DOI][PubMed]
  • 34. Wandeler G, Gsponer T, Bregenzer A, Gunthard HF, Clerc O, Calmy A, et al. Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic. Clin Infect Dis. 2012; 55(10): 1408-16[DOI][PubMed]
  • 35. Cacoub P, Dabis F, Costagliola D, Almeida K, Lert F, Piroth L, et al. Burden of HIV and hepatitis C co-infection: the changing epidemiology of hepatitis C in HIV-infected patients in France. Liver Int. 2015; 35(1): 65-70[DOI][PubMed]
  • 36. Guriev V, Spinu C, Sajen O, Spinu I, Popovici S. Viral hepatitis B, C and HIV coinfection: Evaluation of some immunological and epidemiological aspects. HIV & AIDS Review. 2014; 13(2): 46-9[DOI]
  • 37. Berenguer J, Alejos B, Hernando V, Viciana P, Salavert M, Santos I, et al. Trends in mortality according to hepatitis C virus serostatus in the era of combination antiretroviral therapy. AIDS. 2012; 26(17): 2241-6[DOI][PubMed]
  • 38. Hernando V, Alejos B, Monge S, Berenguer J, Anta L, Vinuesa D, et al. All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997-2010. BMC Infect Dis. 2013; 13: 382[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments